CpG motifs in bacterial DNA trigger direct B-cell activation
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Unmethylated CpG dinucleotides are more frequent in the genomes of bacteria and viruses than of vertebrates. We report here that bacterial DNA and synthetic oligodeoxynucleotides containing unmethylated CpG dinucleotides induce murine B cells to proliferate and secrete immunoglobulin in vitro and in vivo. This activation is enhanced by simultaneous signals delivered through the antigen receptor. Optimal B-cell activation requires a DNA motif in which an unmethylated CpG dinucleotide is flanked by two 5' purines and two 3' pyrimidines. Oligodeoxynucleotides containing this CpG motif induce more than 95% of all spleen B cells to enter the cell cycle. These data suggest a possible evolutionary link between immune defence based on the recognition of microbial DNA and the phenomenon of 'CpG suppression' in vertebrates. The potent immune activation by CpG oligonucleotides has implications for the design and interpretation of studies using 'antisense' oligonucleotides and points to possible new applications as adjuvants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unmethylated CpG motifs in bacterial DNA are potent triggers of inflammation (Klinman et al., 1997; Krieg et al., 1995).”
From Cytoplasmic DNA: sources, sensing, and role in aging and disease (2021) · cites this paper as Krieg et al., 1995
In the citing paper
“CpG DNA is a potent stimulator of TLR9 (12).”
From Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice (2011) · cites this paper as [12]
Citations
Cites
Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
Stein, C. A., & Cheng, Y.-C. (1993) · Science · doi:10.1126/science.8351515 · Cited by 1,303
Gene inhibition using antisense oligodeoxynucleotides
Wagner, R. W. (1994) · Nature · doi:10.1038/372333a0 · Cited by 736
CpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Current concepts in antisense drug design
Milligan, J. F., Matteucci, M. D., & Martin, J. C. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00066a001 · Cited by 566
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331109 · Cited by 562
Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
Agrawal, S., Temsamani, J., & Tang, J. Y. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7595 · Cited by 561
Therapeutic Applications of Oligonucleotides
Crooke, S. T. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001553 · Cited by 446
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Lymphocyte stimulation: a rapid multiparameter analysis.
Darzynkiewicz, Z., Traganos, F., Sharpless, T., & Melamed, M. R. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.8.2881 · Cited by 347
Frequency of B lymphocytes responsive to anti-immunoglobulin.
Defranco, A. L., Raveche, E. S., Asofsky, R., & Paul, W. E. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1523 · Cited by 293
Research works printed but not linked: 1
- Krapf, F., Herrmann, M., Leitmann, W. & Kalden, J. R. Clin. exp. immun. 75, 336–342 (1989).
Cited by
Items 801–900 of 1,013
Therapeutic and Prophylactic Applications of Bacteriophage Components in Modern MedicinePreprint
Adhya, S. L., Merril, C. R., & Biswas, B. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012518 · Cited by 80
Enhancement of Infectious Disease Vaccines Through TLR9-Dependent Recognition of CpG DNA
McCluskie, M. J., & KRIEG, A. M. (2006) · Springer eBooks · doi:10.1007/3-540-32636-7_6 · Cited by 79
Self-citationThe role of toll-like receptors in systemic lupus erythematosus
Rahman, A. H., & Eisenberg, R. A. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0034-3 · Cited by 90
TLR9 and BAFF: Their expression in patients with IgA nephropathy
LI, W., PENG, X., LIU, Y., LIU, H., LIU, F., HE, L., LIU, Y., ZHANG, F., GUO, C., CHEN, G., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2359 · Cited by 80
Beaudette, T. T., Bachelder, E. M., Cohen, J. A., Obermeyer, A. C., Broaders, K. E., Fréchet, J. M. J., Kang, E.-S., Mende, I., Tseng, W. W., Davidson, M. G., et al. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900038e · Cited by 95
Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity
Peschke, K., Achleitner, M., Frenzel, K., Gerbaulet, A., Ada, S. R., Zeller, N., Lienenklaus, S., Lesche, M., Poulet, C., Naumann, R., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600722 · Cited by 79
Zhu, F., Reich, C. F., & Pisetsky, D. S. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01222.x · Cited by 81
Bromidge, S. M., Dabbs, S., Davies, D. T., Davies, S., Duckworth, D. M., Forbes, I. T., Gaster, L. M., Ham, P., Jones, G. E., King, F. D., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990388c · Cited by 79
Blazar, B. R., Krieg, A. Μ., & Taylor, P. A. (2001) · Blood · doi:10.1182/blood.v98.4.1217 · Cited by 79
Self-citationA role for Toll in autoimmunity
Krieg, A. Μ. (2002) · Nature Immunology · doi:10.1038/ni0502-423 · Cited by 79
Self-citationSester, D. P., Beasley, S. J., Sweet, M. J., Fowles, L. F., Cronau, S. L., Stacey, K. J., & Hume, D. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6541 · Cited by 79
Immunoregulatory activity of CpG oligonucleotides in humans and nonhuman primates
Verthelyi, D. I., & Klinman, D. M. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(03)00202-x · Cited by 79
Self-citationTLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Reilley, M. J., Morrow, B., Ager, C. R., Liu, A. J., Hong, D. S., & Curran, M. A. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0811-x · Cited by 83
Taylor, P. A., Ehrhardt, M. J., Lees, C. J., Panoskaltsis‐Mortari, A., Krieg, A. Μ., Sharpe, A. H., Murphy, W. J., Serody, J. S., Hemmi, H., Akira, S., et al. (2008) · Blood · doi:10.1182/blood-2007-09-113670 · Cited by 78
Self-citationCaveolin-1 Deficiency Dampens Toll-Like Receptor 4 Signaling through eNOS Activation
Mirza, M. K., Yuan, J., Gao, X.-P., Garrean, S. M., Brovkovych, V. M., Malik, A. B., Tiruppathì, C., & Zhao, Y. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091088 · Cited by 79
Mahato, R. I., Cheng, K., & Guntaka, R. V. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.3 · Cited by 83
Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2
van den Beucken, J. J. J. P., Walboomers, X. F., Boerman, O. C., Vos, M. R. J., Sommerdijk, N. A. J. M., Hayakawa, T., Fukushima, T., Okahata, Y., Nolte, R. J. M., & Jansen, J. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.016 · Cited by 83
Krieg, A. Μ. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02039-x · Cited by 78
Self-citationKANELLOS, Sylvester, S. R., BUTLER, AMBALI, PARTIDOS, HAMBLIN, & RUSSELL (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00771.x · Cited by 78
Hartl, A. J., Kiesslich, J., Weiss, R., Bernhaupt, A., Mostböck, S., Scheiblhofer, S., Ebner, C., Ferreira, F., & Thalhamer, J. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70533-6 · Cited by 79
Zhang, H., Yan, T., Xu, S., Feng, S., Huang, D., Fujita, M., & Gao, X. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.12.072 · Cited by 77
RIG-I Detects Triphosphorylated RNA of Listeria monocytogenes during Infection in Non-Immune Cells
Hagmann, C. A., Herzner, A., Abdullah, Z., Zillinger, T., Jakobs, C., Schuberth, C., Coch, C., Higgins, P. G., Wisplinghoff, H., Barchet, W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062872 · Cited by 92
He, H., Lowry, V. K., Swaggerty, C. L., Ferro, P. J., & Kogut, M. H. (2004) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2004.07.009 · Cited by 77
Elías, F., Fló, J., López, R. A., Zorzópulos, J., Montaner, A. D., & Rodriguez, J. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3697 · Cited by 78
von Meyenn, F., Schaefer, M. H., Weighardt, H., Bauer, S., Kirschning, C. J., Wagner, H., & Sparwasser, T. D. (2006) · Immunobiology · doi:10.1016/j.imbio.2006.05.004 · Cited by 85
Mittal, S. K., Aggarwal, N., Sailaja, G. S., van Olphen, A. L., HogenEsch, H., North, A., Hays, J. P., & Moffatt, S. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00170-5 · Cited by 77
DNA and a CpG Oligonucleotide Derived fromBabesia bovisAre Mitogenic for Bovine B Cells
Brown, W. C., Estes, D. M., Chantler, S. E., Kegerreis, K. A., & Suarez, C. E. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5423-5432.1998 · Cited by 77
Factors controlling the turnover of T memory cells
Sprent, J., Tough, D. F., & Sun, S. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00960.x · Cited by 77
Prophylactic and therapeutic implications of toll-like receptor ligands
Hedayat, M., Takeda, K., & Rezaei, N. (2012) · Medicinal Research Reviews · doi:10.1002/med.20214 · Cited by 76
Cell-Free Fetal DNA, Telomeres, and the Spontaneous Onset of Parturition
Phillippe, M. (2015) · Reproductive Sciences · doi:10.1177/1933719115592714 · Cited by 83
Corbett, A. J., Caminschi, I., McKenzie, B. S., Brady, J. L., Wright, M. D., Mottram, P. L., Hogarth, P. M., Hodder, A. N., Zhan, Y., Tarlinton, D. M., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526100 · Cited by 76
Schädlich, L., Senger, T., Kirschning, C. J., Müller, M., & Gissmann, L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.014 · Cited by 76
Sivori, S., Carlomagno, S., Moretta, L., & Moretta, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200535781 · Cited by 76
Pázmándi, K., Agod, Z., Kumar, B. V., Szabó, A., Fekete, T., Sógor, V., Veres, Á. N., Boldogh, I. R., Rajnavölgyi, É., Lányi, Á., et al. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.028 · Cited by 83
Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers
Borges, O., Lebre, F., Bento, D., Borchard, G., & Junginger, H. E. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-0011-3 · Cited by 77
Nakano, S., Morimoto, S., Suzuki, J., Nozawa, K., Amano, H., Tokano, Y., & Takasaki, Y. (2007) · Rheumatology · doi:10.1093/rheumatology/kem327 · Cited by 76
Baldwin, S. L., D'Souza, C. D., Orme, I. M., Liu, M. A., Huygen, K., Denis, O., Tang, A., Zhu, L., Montgomery, D. L., & Ulmer, J. B. (1999) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0196 · Cited by 76
Perspectives in asthma: Molecular use of microbial products in asthma prevention and treatment
Racila, D. M., & Kline, J. N. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.08.050 · Cited by 76
The bidirectional capacity of bacterial antigens to modulate allergy and asthma
Renz, H., & Herz, U. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00254202 · Cited by 87
Lund, F. E. (2006) · Molecular Medicine · doi:10.2119/2006-00099.lund · Cited by 75
Sakurai, F., Terada, T., Yasuda, K., Yamashita, F., Takakura, Y., & Hashida, M. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301784 · Cited by 76
Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments
Stein, C. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00143-8 · Cited by 76
Smith, J. B., & Wickstrom, E. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.15.1146 · Cited by 76
The microbiome in anti-cancer therapy
Bashiardes, S., Tuganbaev, T., Federici, S., & Elinav, E. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.04.001 · Cited by 80
Sato, T., Yamamoto, M., Shimosato, T., & Klinman, D. M. (2010) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2010.00632.x · Cited by 76
Self-citationGoto, T., Bandoh, N., Yoshizaki, T., Nozawa, H., Takahara, M., Ueda, S., Hayashi, T., & Harabuchi, Y. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.003 · Cited by 75
Marie, C., Vandermeulen, G., Quiviger, M., Richard, M., Véronique Préat, A., & Scherman, D. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1441 · Cited by 75
Karbach, J., Neumann, A., Atmaca, A., Wahle, C., Brand, K., von Boehmer, L., Knuth, A., Bender, A., Ritter, G., Old, L. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1811 · Cited by 76
Lu, M., Zhang, M., Takashima, A., Weiss, J. P., Apicella, M. A., Li, X., Yuan, D., & Munford, R. S. (2005) · Nature Immunology · doi:10.1038/ni1246 · Cited by 75
Hayashi, T., Rao, S. P., Takabayashi, K., Van Uden, J. H., Kornbluth, R. S., Baird, S. M., Taylor, M. W., Carson, D. A., Catanzaro, A., & Raz, E. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6156-6164.2001 · Cited by 75
Differences in Macrophage Activation by Bacterial DNA and CpG-Containing Oligonucleotides
Roberts, T. L., Dunn, J. A., Terry, T. D., Jennings, M. P., Hume, D. A., Sweet, M. J., & Stacey, K. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3569 · Cited by 75
Carvalho, C. M., Costa, A. R., Silva, F. C., & Oliveira, A. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2016.1271309 · Cited by 78
Borsutzky, S., Kretschmer, K., Becker, P. D., Mühlradt, P. F., Kirschning, C. J., Weiß, S., & Guzmán, C. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6308 · Cited by 86
Yi, A., Yoon, J.-G., Hong, S., Redford, T. W., & Krieg, A. Μ. (2001) · International Immunology · doi:10.1093/intimm/13.11.1391 · Cited by 75
Self-citationAntitumor vaccination: where we stand.
Bocchia, M., Bronte, V., Colombo, M. P., Vincentiis, A. D., Nicola, M. D., Forni, G., Lanata, L., Lemoli, R. M., Massaia, M., Rondelli, D., et al. (2000) · PubMed · Cited by 93
5-Hydroxytryptamine 2C (5-HT2C) Receptor Agonists as Potential Antiobesity Agents
Nilsson, B. M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm058240i · Cited by 75
Bacteria and Host Interplay in Staphylococcus aureus Septic Arthritis and Sepsis
Jin, T., Mohammad, M., Pullerits, R., & Ali, A. (2021) · Pathogens · doi:10.3390/pathogens10020158 · Cited by 76
Review: the human cutaneous microflora and factors controlling colonisation
Bojar, R. A., & Holland, K. T. (2002) · World Journal of Microbiology and Biotechnology · doi:10.1023/a:1021271028979 · Cited by 82
High throughput production of mouse monoclonal antibodies using antigen microarrays
Masi, F. D., Chiarella, P., Wilhelm, H., Massimi, M., Bullard, B., Ansorge, W. J., & Sawyer, A. M. (2005) · PROTEOMICS · doi:10.1002/pmic.200401279 · Cited by 76
Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides
Zhang, H., & Gao, X. (2016) · Materials Science and Engineering C · doi:10.1016/j.msec.2016.03.045 · Cited by 80
Nucleic Acid-Based Approaches for Tumor Therapy
Hager, S., Fittler, F. J., Wagner, E., & Bros, M. (2020) · Cells · doi:10.3390/cells9092061 · Cited by 81
Rankin, R., Pontarollo, R. A., Gomis, S. M., Karvonen, B., Willson, P. J., Loehr, B. I., Godson, D. L., Babiuk, L. A., Hecker, R., & den Hurk, S. V. D. L.-V. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00216-5 · Cited by 82
Recognition of nucleic acid and nucleic acid analogs by Toll-like receptors 7, 8 and 9
Bauer, S., Pigisch, S., Hangel, D., Kaufmann, A. M., & Hamm, S. (2007) · Immunobiology · doi:10.1016/j.imbio.2007.10.010 · Cited by 87
Tirosh, B., Iwakoshi, N. N., Glimcher, L. H., & Ploegh, H. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050575 · Cited by 75
Krug, A., Rothenfußer, S., Selinger, S., Bock, C., Kerkmann, M., Battiany, J., Sarris, A., Giese, T., Speiser, D. E., Endres, S., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3468 · Cited by 74
Epstein, S. L., Stack, A., Misplon, J. A., Lo, C.-Y., Mostowski, H. S., Bennink, J. R., & Subbarao, K. (2000) · International Immunology · doi:10.1093/intimm/12.1.91 · Cited by 74
Immune Mechanisms and Therapeutic Potential of CpG Oligodeoxynucleotides
Wilson, H. L., Dar, A. M., Napper, S., Lopez, A. M., Babiuk, L. A., & Mutwiri, G. (2006) · International Reviews of Immunology · doi:10.1080/08830180600785868 · Cited by 81
Protective Efficacy of DNA Vaccines against Duck Hepatitis B Virus Infection
Triyatni, M., Jilbert, A. R., Qiao, M., Miller, D. S., & Burrell, C. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.84-94.1998 · Cited by 74
CpG Oligodeoxynucleotides Down-Regulate Macrophage Class II MHC Antigen Processing
Chu, R. S., Askew, D., Noss, E. H., Tobian, A., Krieg, A. M., & Harding, C. V. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1188 · Cited by 74
Self-citationMagnusson, M., Magnusson, S., Vallin, H., Rönnblom, L., & Alm, G. V. (2001) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2001.01018.x · Cited by 74
Microbial/host interactions in health and disease: Who controls the cytokine network?
Henderson, B. E., Poole, S., & Wilson, M. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00144-0 · Cited by 76
Innate immune memory in mammals
Hamon, M. A., & Quintin, J. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.05.003 · Cited by 88
Impact of guanidine-containing backbone linkages on stereopure antisense oligonucleotides in the CNS
Pachamuthu, K., Liu, Y., Aduda, V., Akare, S., Alam, R., Andreucci, A., Boulay, D., Bowman, K., Byrne, M., Cannon, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac037 · Cited by 79
Impaired Toll-like Receptor 9 Expression in Alveolar Macrophages with No Sensitivity to CpG DNA
Suzuki, K., Suda, T., Naito, T., Ide, K., Chida, K., & Nakamura, H. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1078oc · Cited by 73
Topical Immunomodulation in Dermatology: Potential of Toll-like Receptor Agonists
Hengge, U. R., & Ruzicka, T. (2004) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2004.30335.x · Cited by 73
Hurtado, P. R., Jeffs, L., Nitschke, J., Patel, M., Sarvestani, G. T., Cassidy, J., Hissaria, P., Gillis, D., & Peh, C. A. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-34 · Cited by 80
Meng, W., Yamazaki, T., Nishida, Y., & Hanagata, N. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-88 · Cited by 74
Tumor Cell Loaded Type-1 Polarized Dendritic Cells Induce Th1-Mediated Tumor Immunity
Hokey, D. A., Larregina, A. T., Erdös, G., Watkins, S. C., & Falo, L. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1692 · Cited by 74
Nucleic Acid Nanostructures for Biomedical Applications
Smith, D. M., Schüller, V. J., Engst, C., Rädler, J. O., & Liedl, T. (2012) · Nanomedicine · doi:10.2217/nnm.12.184 · Cited by 78
Price, A. M., Dai, J., Bazot, Q., Patel, L., Nikitin, P. A., Djavadian, R., Winter, P. S., Salinas, C. A., Barry, A. P., Wood, K. C., et al. (2017) · eLife · doi:10.7554/elife.22509 · Cited by 76
Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
Chuang, Y.-C., Tseng, J., Huang, L.-R., Huang, C., Huang, C. F., & Chuang, T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01075 · Cited by 79
Kwant, A., & Rosenthal, K. L. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.059 · Cited by 73
Lee, S. W., Song, M., Baek, K. H., Park, Y., Kim, J. K., Lee, C. H., Cheong, H., Cheong, C., & Sung, Y. C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3631 · Cited by 73
DNA Nanostructure‐Based Systems for Intelligent Delivery of Therapeutic Oligonucleotides
Hu, Q., Wang, S., Wang, L., Gu, H., & Fan, C. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701153 · Cited by 72
Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control
Bivona, A. E., Alberti, A. S., Cerny, N., Trinitario, S. N., & Malchiodi, E. L. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165658 · Cited by 103
Haabeth, O. A. W., Lohmeyer, J. J. K., Sallets, A., Blake, T. R., Sagiv-Barfi, I., Czerwinski, D. K., McCarthy, B., Powell, A. E., Wender, P. A., Waymouth, R. M., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00361 · Cited by 77
Ali, M. F., Driscoll, C. B., Walters, P., LIMPER, A. H., & Carmona, E. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500559 · Cited by 72
Pontarollo, R. A., Babiuk, L. A., Hecker, R., & den Hurk, S. V. D. L. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-12-2973 · Cited by 72
Fukuiwa, T., Sekine, S., Kobayashi, R., Suzuki, H., Kataoka, K., Gilbert, R. S., Kurono, Y., Boyaka, P. N., Krieg, A. Μ., McGhee, J. R., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.091 · Cited by 72
Self-citationChristie, R. J., Nishiyama, N., & Kataoka, K. (2009) · Endocrinology · doi:10.1210/en.2009-1045 · Cited by 73
Carpentier, A. F. (2003) · Frontiers in bioscience · doi:10.2741/934 · Cited by 72
Bacterial CpG-DNA Licenses TLR9
Bauer, S., & Wagner, H. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59430-4_9 · Cited by 72
Inhibition of Murine Macrophage IL-12 Production by Natural and Synthetic DNA
Pisetsky, D. S., & Reich, C. F. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4897 · Cited by 72
Yu, D. S., Zhao, Q., Kandimalla, E. R., & Agrawal, S. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00537-0 · Cited by 72
Lu, Y., Xin, K.-Q., Hamajima, K., Tsuji, T., Aoki, I., YANG, J., Sasaki, S., FUKUSHIMA, J., Yoshimura, T., TODA, S., et al. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00793.x · Cited by 75
Latz, E., Visintin, A., Espevik, T., & Golenbock, D. T. (2004) · Journal of Endotoxin Research · doi:10.1177/09680519040100060501 · Cited by 72
Plasmid DNA expression systems for the purpose of immunization
Davis, H. L. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80041-9 · Cited by 72
Pontarollo, R. A., Rankin, R., Babiuk, L. A., Godson, D. L., Griebel, P. J., Hecker, R., KRIEG, A. M., & den Hurk, S. V. D. L. (2002) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(01)00379-8 · Cited by 72
Self-citationCpG DNA: recognition by and activation of monocytes
Klinman, D. M., Takeshita, F., Gürsel, İ., Leifer, C. A., Ishii, K. J., Verthelyi, D. I., & Gürsel, M. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)01614-3 · Cited by 78
Self-citationCpG motifs induce Langerhans cell migration in vivo
Ban, E., Dupré, L., Hermann, E., Rohn, W. M., Vendeville, C., Quatannens, B., Ricciardi‐Castagnoli, P., Capron, A., & Riveau, G. J. (2000) · International Immunology · doi:10.1093/intimm/12.6.737 · Cited by 73
Metadata
- Authors
- Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M.
- Affiliations
- University of Iowa (US)
- Center for Biologics Evaluation and Research (US)
- ORCID
- Venue
- Nature
- Published
- 1995-04
- Volume
- 374
- Issue
- 6522
- Pages
- 546-549
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2047366876
- Cited by
- 3,508
- References
- 28
- Citations by year
- 2026: 24 · 2025: 36 · 2024: 47 · 2023: 43 · 2022: 58 · 2021: 58 · 2020: 84 · 2019: 84 · 2018: 58 · 2017: 69 · 2016: 76 · 2015: 89 · 2014: 83 · 2013: 102 · 2012: 104
- FWCI
- 36.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- CpG motifs, bacterial DNA, B cell activation, B cell proliferation, immunoglobulin secretion, antigen receptor signaling, CpG oligodeoxynucleotides, CpG suppression, antisense oligonucleotides, adjuvants
- MeSH terms
- Animals, B-Lymphocytes, Base Sequence, Cell Line, DNA, Bacterial, Escherichia coli, Lymphocyte Activation, Methylation, Mice, Inbred DBA, Molecular Sequence Data, Oligodeoxyribonucleotides, T-Lymphocytes, Dinucleoside Phosphates, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.